These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1153607)

  • 1. [Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)].
    Oliver-Marti n R; Buschsenschultz E; Pichot P; Boissier J
    Psychopharmacologia; 1975; 41(2):187-95. PubMed ID: 1153607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Shea C; Tabrizi MA; Stiller RL
    J Am Acad Child Psychiatry; 1979; 18(4):616-27. PubMed ID: 541469
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine blood levels and clinical outcome.
    Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and diagnostic classification and serum drug levels: relation to antidepressive effect of imipramine.
    Møller SE; Reisby N; Elley J; Krautwald O; Ortmann J; Larsen OB
    Neuropsychobiology; 1985; 13(4):160-6. PubMed ID: 4047380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The association of imipramine and desipramine in the treatment of depressions].
    Spina A
    Acta Neurol (Napoli); 1971; 26(4):490-5. PubMed ID: 5132829
    [No Abstract]   [Full Text] [Related]  

  • 10. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel JM; Michelson L
    J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M; Perel J; Michelson L
    Psychopharmacol Bull; 1984; 20(1):123-5. PubMed ID: 6718637
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative clinical evaluation of lofepramine and imipramine. Pharmacological aspects.
    Siwers B; Borg S; d'Elia G; Lundin G; Forshell GP; Raotma H; Román G
    Acta Psychiatr Scand; 1977 Jan; 55(1):21-31. PubMed ID: 320828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.
    Daniel W
    Pol J Pharmacol Pharm; 1991; 43(3):197-206. PubMed ID: 1683700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous depression and imipramine levels in the blood.
    Costa D; Predescu V; Vişan-Ionescu I; Ciurezu T
    Psychopharmacology (Berl); 1980; 70(3):291-4. PubMed ID: 6777803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An explanatory statistical model for plasma levels of imipramine and desmethylimipramine during long-term therapy.
    Roberts CD; Roberts EN
    Br J Psychiatry; 1973 Jun; 122(571):736-7. PubMed ID: 4716078
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
    Sabelli HC; Fawcett J; Javaid JI; Bagri S
    Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased plasma concentrations of imipramine and desipramine following cholestyramine intake in depressed patients.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Ther Drug Monit; 1994 Aug; 16(4):432-4. PubMed ID: 7974637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.